Psychogenic Syncope
Referanslar
van Dijk JG, Wieling W. Pathophysiological basis of syncope and neurological conditions that mimic syncope. Progress in cardiovascular diseases. 2013;55:345-356. doi:10.1016/j.pcad.2012.10.016
van Dijk JG, Thijs RD, Benditt DG, Wieling W. A guide to disorders causing transient loss of consciousness: focus on syncope. Nature Reviews Neurology 2009;5:438-448. doi:10.1038/nrneurol.2009.99
Saal DP, van Dijk JG. Classifying syncope. Autonomic Neuroscience: Basic and Clinical
2014;184:3-9. doi: 10.1016/j.autneu.2014.05.007
Shen WK, Sheldon RS, Benditt DG, Cohen MI, et.al. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Journal Of The American College Of Cardiology 2017;70:620-663. doi:10.1016/ j.jacc.2017.03.002
Probst MA, Kanzaria HK, Gbedemah M, Richardson LD, et.al. National trends in resource utilization associated with ED visits for syncope. American Journal of Emergency Medicine 2015;33:998-1001. doi:10.1016/j.ajem.2015.04.030
Freeman R, Wieling W, Axelrod FB, Benditt DG, et.al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Autonomic Neuroscience: Basic and Clinical. 2011;161:46-48 11 doi:10.1016/j.autneu.2011.02.004
Hanna EB. Syncope: etiology and diagnostic approach. Cleveland Clınıc Journal Of Medıcıne 2014;81:755-766.doi:10.3949/ccjm.81a.13152.
Soteriades ES, Evans JC, Larson MG, Chen MH, et.al. Incidence and prognosis of syncope.
New England Journal of Medicine. 2002;347:878-885. doi: 10.1056/NEJMoa012407
Brignole M, Menozzi C, Bartoletti A, Giada F, et.al. A new management of syncope: prospective systematic guideline-based evaluation of patients referred urgently to general hospitals. European Heart Journal. 2005;27:76-82
doi: 10.1093/eurheartj/ehi647
Shen W-K, Sheldon RS, Benditt DG, Cohen MI, et.al. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Journal of the American College of Cardiology. 2017;70:e39-e110.
doi: 10.1016/j.jacc.2017.03.003
Raj V, Rowe AA, Fleisch SB, Paranjape SY, et.al. Psychogenic pseudosyncope: diagnosis and management. Autonomic Neuroscience 2014;184:66-72.
doi: 10.1016/j.autneu.2014.05.003
Tannemaat MR, Thijs RD, van Dijk JG. Managing psychogenic pseudosyncope: Facts and experiences. Cardiology Journal. 2014;21:658-664. doi: 10.5603/CJ.a2014.0070
Espay AJ, Aybek S, Carson A, Edwards MJ, et.al. Current Concepts in Diagnosis and Treatment of Functional Neurological Disorders. JAMA Neurology 2018;75:1132-1141. doi: 0.1001/jamaneurol.2018.1264
Black DW, Grant JE: DSM-5® guidebook: the essential companion to the diagnostic and statistical manual of mental disorders, American Psychiatric Publishing; 2014.
Aybek S, Perez DL. Diagnosis and management of functional neurological disorder.
British Medical Journal 2022;376:o64. doi: 10.1136/bmj.o64.
Blitzstein SM. Recognizing and treating conversion disorder. AMA Journal of Ethics.
2008;10:158-160. doi: 10.1001/virtualmentor.2008.10.3.cprl1-0803
Ludwig L, Pasman JA, Nicholson T, et.al. Stressful life events and maltreatment in conversion (functional neurological) disorder: systematic review and meta-analysis of case- control studies. The Lancet Psychiatry. 2018;5:307-320.
doi: 10.1016/ S2215-0366(18)30051-8.
Barbey A, Pjanic I, Studer H, Bischoff N, et.al. Management of Functional Neurological Disorders (FND): Experience from a Swiss FND Clinic. Clinical and Translational Neuroscience. 2022;6. doi: 10.3390/ctn6010002
Feinstein A. Conversion disorder: advances in our understanding. Canadian Medical Association Journal. 2011;183:915-920. doi: 10.1503/cmaj.110490
Kanjwal K, Kanjwal Y, Karabin B, Grubb BP. Psychogenic syncope? A cautionary note.
Pacing and Clinical Electrophysiology 2009;32:862-865. doi:10.1111/j.1540-8159.2009.02400
Brignole M, Moya A, de Lange FJ, Deharo J-C, et.al. Practical Instructions for the 2018 ESC Guidelines for the diagnosis and management of syncope. European Heart Journal. 2018;39:e43-e80. doi: 10.1093/eurheartj/ehy071
Aponte-Becerra L, Novak P. Tilt Test: A Review. Journal of Clinical Neurophysiology
2021;38:279-286. doi: 10.1097/WNP.0000000000000625
Claffey P, Perez-Denia L, Rivasi G, Finucane C, et.al. Near-infrared spectroscopy in evaluating psychogenic pseudosyncope-a novel diagnostic approach. QJM: An International Journal of Medicine. 2020;113:239-244. doi: 10.1093/qjmed/hcz257
Liao Y, Du J, Benditt DG, Jin H. Vasovagal syncope or psychogenic pseudosyncope: a major issue in the differential diagnosis of apparent transient loss of consciousness in children. Science Bulletin 2022;67:1618-1620. doi: 10.1016/j.scib.2022.07.024
Mereu R, Sau A, Lim PB. Diagnostic algorithm for syncope. Autonomic Neuroscience
2014;184:10-16. doi:10.1016/j.autneu.2014.05.008
Saal DP, Overdijk MJ, Thijs RD, van Vliet IM, et.al. Long-term follow-up of psychogenic pseudosyncope. American Academy of Neurology. 2016;87:2214-2219.
doi: 10.1212/WNL.0000000000003361
Alciati A, Shiffer D, Dipaola F, Barbic F, et.al. Psychogenic pseudosyncope: clinical features, diagnosis and management. Journal of Atrial Fibrillation. 2020;13
doi: 10.4022/jafib.2399
Rosebush PI, Mazurek MF. Treatment of conversion disorder in the 21st century: have we moved beyond the couch? Current Treatment Options in Neurology (2011) 13:255–266 doi:10.1007/s11940-011-0124-y
Abdurrachid N, Marques JG. Munchausen syndrome by proxy (MSBP): a review regarding perpetrators of factitious disorder imposed on another (FDIA). CNS spectrums. 2022;27:16-26. doi: 10.1017/S1092852920001741
Durrant J, Rickards H, Cavanna AE. Prognosis and outcome predictors in psychogenic nonepileptic seizures. Epilepsy research and treatment. 2011;2011.
doi: 10.1111/epi.12106
Gutkin M, McLean L, Brown R, Kanaan RA. Systematic review of psychotherapy for adults with functional neurological disorder. Journal of Neurology, Neurosurgery, and Psychiatry. 2020. doi: 10. 1136/ jnnp- 2019- 321926.
Russell L, Abbass A, Allder S. A review of the treatment of functional neurological disorder with intensive short-term dynamic psychotherapy. Epilepsy & Behavior 2022;130:108657. doi: 10.1016/j.yebeh.2022.108657.
Baslet G, Ehlert A, Oser M, Dworetzky BA. Mindfulness-based therapy for psychogenic nonepileptic seizures. Epilepsy & Behavior. 2020;103:106534.
doi: 10.1016/j.yebeh.2019.106534
Myers L, Sarudiansky M, Korman G, Baslet G. Using evidence-based psychotherapy to tailor treatment for patients with functional neurological disorders. Epilepsy & Behavior Reports 2021;16:100478. doi: 10.1016/j.ebr.2021.100478.
O'Connell N, Nicholson T, Blackman G, Tavener J, et.al. Medication prescriptions in 322 motor functional neurological disorder patients in a large UK mental health service: A case control study. General Hospital Psychiatry 2019;58:94-102.
doi: 10.1016/j.genhosppsych.2019.04.004.
Ghanbarizadeh SR, Dinpanah H, Ghasemi R, Salahshour Y, et.al. Quetiapine versus Haloperidol in Controlling Conversion Disorder Symptoms; a Randomized Clinical Trial. Emergency. 2018;6. PMID: 30584563
Pintor L, Baillés E, Matrai S, Carreno M, et.al. Efficiency of venlafaxine in patients with psychogenic nonepileptic seizures and anxiety and/or depressive disorders. The Journal of neuropsychiatry and clinical neurosciences. 2010;22:401-408. doi:10.1176/jnp.2010.22.4.401
Hinson VK, Haren WB. Psychogenic movement disorders. The Lancet Neurology. 2006;5:695-700. doi: 10.1016/S1474-4422(06)70523-3
Hurwitz TA. Somatization and conversion disorder. The Canadian Journal of Psychiatry. 2004;49:172-178. doi: 10.1177/070674370404900304
LaFrance WC, Baird GL, Barry JJ, Blum AS, et.al. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA psychiatry. 2014;71:997- 1005.
doi: :10.1001/jamapsychiatry.2014.817
